The ANA GENLISA ELISA is intended for the qualitative screening of anti-nuclear IgG antibodies in human serum and plasma.
The Toxoplasma gondii IgM GENLISA ELISA is intended for the qualitative determination of Toxoplasma gondii IgM antibody in human serum and plasma. Pack Size - ELISA 96 wells
The Rubella IgM GENLISATM ELISA is intended for the qualitative determination of Rubella Virus IgM class antibodies in human serum and plasma. Pack Size - ELISA 96 wells
The Rubella IgG GENLISATM ELISA is intended for the qualitative determination of Rubella Virus IgG class antibodies in human serum and plasma. ELISA 96 wells
The HSV 1 & 2 IgG GENLISA ELISA is intended for the qualitative determination of HSV 1 & 2 IgG in human serum and plasma. Pack Size - ELISA 96 wells
The HSV 1 IgM GENLISA ELISA is intended for the qualitative determination of HSV 1 IgM in human serum and plasma.
The HSV 1 IgG GENLISA ELISA is intended for the qualitative determination of HSV 1 IgG in human serum and plasma. Pack Size - ELISA 96 wells
The CMV IgM GENLISA ELISA is intended for the qualitative determination of CMV IgM in human serum and plasma. ELISA 96 wells
The Varicella-Zoster Virus (VZV) IgM ELISA is intended for the qualitative determination of IgM class antibodies against Varicella-Zoster Virus (VZV) in human serum or plasma (citrate, heparin). ELISA 96 wells
The Varicella-Zoster Virus (VZV) IgG ELISA is intended for the qualitative determination of IgG class antibodies against Varicella-Zoster Virus (VZV) in human serum or plasma (citrate, heparin).
The HEV IgM GENLISA ELISA is intended for the qualitative determination of Hepatitis E Virus IgM in human serum and plasma.
COVID 19 Antibody Test Kits COVID 19 NIV Test Kits
One step, rapid immunochromatographic assay for detectionof NS1Ag of all serotypes of Dengue virus in human serum orplasmaDetection of infection prior to sero - conversionDetects all serotypes (DEN-1,DEN-2,DEN-3, DEN-4)Specimen volume : 90 - 100 ul of Serum/PlasmaNo sample preparation requiredResult interpretation time: 20 minsSensitivity :> 95%. Specificity : =95%
Testing 1
Test Test Test Test Test Test
test test test test test test test test test test test test test test test test test test test test test test test test test test test
Anti-SARS-CoV-2 Rapid Test, COVID-19 1. Easier: No special equipment needed, Intuitive visual interpretation. 2. Rapid: Quick sampling by fingertip blood, Results in 10-15min. 3. Accurate: Results with IgG and IgM respectively. 4. Application: as screening tool for potential suspect patients in large numbers. Testing kit is FDA Emergency Use Authorization (EUA) Approved Testing kit is CE MARKED-IVD * Instruction for Use * Interpretation Guide * SARS-CoV-2 immunoassays * Accuracy of the Anti-SARS-CoV-2 Rapid Test Kit * Anti-SARS Rapid Test Brochure * COVID-19 Catalog * EUA Approval Letter * Fact Sheet for Healthcare Providers * FDA Letter * Fact Sheet for Recipients * FAQ * CE IVD Notification Certificate Antibody Performance Measure Estimate of Performance 95% Confidence Interval IgM Sensitivity (PPA) 95.7% (289/302) (92.8%; 97.5%) IgM Specificity (NPA) 99.7% (311/312) (98.2%; 99.9%) IgG Sensitivity (PPA) 99.0% (299/302) (97.1%; 99.7%) IgG Specificity (NPA) 99.4% (310/312) (97.7%; 99.8%) Combined Sensitivity (PPA) 99.0% (299/302) (97.1%; 99.7%) Combined Specificity (NPA) 99% (309/312) (97.2%; 99.7%) Combined PPV at prevalence = 5% 84.4% (64.6%; 94.6%) Combined NPV at prevalence = 5% 99.9% (99.8%; 100%) Testing kit is FDA Emergency Use Authorization (EUA) Approved Testing kit is CE MARKED-IVD * Instruction for Use * Interpretation Guide * SARS-CoV-2 immunoassays * Accuracy of the Anti-SARS-CoV-2 Rapid Test Kit * Anti-SARS Rapid Test Brochure * COVID-19 Catalog * EUA Approval Letter * Fact Sheet for Healthcare Providers * FDA Letter * Fact Sheet for Recipients * FAQ * CE IVD Notification Certificate
Product Details: Number of Reactions(Preps)/Kit :30T Brand : SD Biosensor ICMR Approved : Yes Result Time (Rapid Kits) : 10 min CAT No : RK019-30 STANDARD Q HIV 1/2 Ab 3-Line performs qualitative analysis by detecting antibodies specific to HIV-1 (including Group O) and HIV-2 in serum, plasma and whole blood using immunochromatography. With a simple test method, HIV infection status can be discriminated, and with its high sensitivity and specificity, the screening test result can be obtained within 10 minutes. Easy to use, Easy to read and interpret Discrimination between HIV-1 and HIV-2 antibodies Room temperature storage Performance Sensitivity : 100% (74/74)/ Specificity : 100% (232/232)
A rapid in vitro qualitative immunoassay for detection of antibodies to the Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) Clear, dependable results in 15 minutes Requires minimal training and no equipment So easy it can be used at the lowest levels of health care service Can use whole blood or serum/plasma Collection can be by fingerstick or venipuncture No refrigeration required Storage conditions 2-30�°C
COVID-19 Ag Rapid Test Device is an in vitro diagnostic rapidtest for the qualitative detection of antigen (Ag) in humannasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. COVID-19 Ag RapidTest Device is for professional use only and is intended to be used asan aid in the diagnosis of
